|
⚲
|
| Keyboard |
| Dunn Edmund
✚
|
|
|---|---|
| CIK # | 0001989401 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001989401] | |
| 4 | [0001989401] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Monte Rosa Therapeutics Inc | |
| Dunn Edmund |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-03-04 | Sell | 139 | $17.96 | 2,496 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-03-02 | Sell | 536 | $17.50 | 9,380 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-03-02 | Option exercise | 536 | $13.41 | 7,188 |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Option exercise | 536 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-02-27 | Option exercise | 25,164 | $13.41 | 337,449 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-02-27 | Sell | 25,164 | $18.10 | 455,468 |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2026-02-27 | Option exercise | 25,164 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-05 | Sell | 1,039 | $15.17 | 15,762 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2025-06-03 | Sell | 2,062 | $4.45 | 9,176 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2025-01-02 | Grant | 11,850 | ||
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2025-01-02 | Grant | 53,400 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2024-07-05 | Sell | 1,610 | $3.83 | 6,166 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2024-06-03 | Sell | 1,207 | $4.04 | 4,876 |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2024-01-02 | Grant | 25,000 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2024-01-02 | Grant | 35,900 | $0.00 |